Clinical Trials Browser

Phase NA × Gliosarcoma × 90 days × Clear all

NCT03115333 2026-03-02

DSC-MRI in Measuring rCBV for Early Response to Bevacizumab in Patients With Recurrent Glioblastoma

Phase NA Active not recruiting

Glioblastoma, Gliosarcoma